TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11796346

Group type: EXPERIMENTAL
Intervention: Didanosine encapsulated enteric bead formulation (400 mg) with indinavir (800 mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Didanosine encapsulated enteric bead formulation (400 mg) with ketoconazole (200 mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Didanosine encapsulated enteric bead formulation (400 mg) with ciprofloxacin (750 mg)
Number of subjects: 63
Study: 10404825

Group type: EXPERIMENTAL
Intervention: Hexarelin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hexarelin plus CRH
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CRH
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 15
Study: 7748217

Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ) 3 gm/day
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ)
Number of subjects: 351
Study: 2109121

Group type: EXPERIMENTAL
Intervention: Hausmann Lipid 20%
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lipovenös 20%
Number of subjects: 13

Group type: COMPARATOR
Intervention: Intralipid 20%
Number of subjects: 13
Study: 379052

Group type: EXPERIMENTAL
Intervention: Ultrasonic instrumentation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hand instrumentation
Number of subjects: 18
Study: 31825499

Group type: EXPERIMENTAL
Intervention: CDSS intervention group (3242 patients)
Number of subjects: 6480

Group type: COMPARATOR
Intervention: Control group (3238 patients)
Number of subjects: 6480

Group type: EXPERIMENTAL
Intervention: CDSS intervention group
Number of subjects: 6480
Study: 28956706

Group type: EXPERIMENTAL
Intervention: Enhanced Physical Activity Intervention (EPAI)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Caregiver Skill Building Intervention (CSBI)
Number of subjects: 211
Study: 25853611

Group type: EXPERIMENTAL
Intervention: CROS hearing aid
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: BAHD
Number of subjects: 8
Study: 23278176

Group type: EXPERIMENTAL
Intervention: Vitamins C (1400 mg) and E (800 mg) supplementation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 20492527

Group type: EXPERIMENTAL
Intervention: Topical OLEOZON(®), applied two times per day for 3 months
Number of subjects: 400

Group type: COMPARATOR
Intervention: Ketoconazole cream 2%, applied two times per day for 3 months
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Topical OLEOZON(®)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Ketoconazole cream 2%
Number of subjects: 400
Study: 19652547

Group type: EXPERIMENTAL
Intervention: Participation in the vaccine trial
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Joint decision-making within households
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Lack of information and negative information
Number of subjects: 503
Study: 17275896

Group type: EXPERIMENTAL
Intervention: Walking intervention
Number of subjects: 24
Study: 12680737

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.0 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1.2 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10760556

Group type: EXPERIMENTAL
Intervention: Unilateral ECT with antidepressant drugs (Group-1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unilateral ECT with drug placebo (Group-2)
Number of subjects: 30
Study: 8822997

Group type: EXPERIMENTAL
Intervention: Low-saturated-fat, low-cholesterol diet with dietary counseling
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group with unrestricted diet
Number of subjects: 1062
Study: 1448485

Group type: EXPERIMENTAL
Intervention: Marijuana smoking
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Prolonged breath holding
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 3881924

Group type: EXPERIMENTAL
Intervention: High carbohydrate, low fat diet (65% carbohydrate, 20% fat, 15% protein) for six weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control diet (45% carbohydrate, 40% fat, 15% protein) for four weeks
Number of subjects: 6
Study: 30777070

Group type: EXPERIMENTAL
Intervention: artesunate + amodiaquine (AS + AQ)
Number of subjects: 749

Group type: COMPARATOR
Intervention: artesunate + sulfadoxine‐pyrimethamine (AS + SP)
Number of subjects: 749

Group type: COMPARATOR
Intervention: artesunate (AS)
Number of subjects: 749
Study: 29985669

Group type: EXPERIMENTAL
Intervention: 30-min pre-exercise nap (NAP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group without pre-exercise nap (CON)
Number of subjects: 61
Study: 27348250

Group type: COMPARATOR
Intervention: GSK TIV
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Sinovac TIV
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Pasteur TIV
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: All TIVs
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Sinovac TIV, Pasteur TIV, GSK TIV
Number of subjects: 292
Study: 24670677

Group type: EXPERIMENTAL
Intervention: Challenging popular tags (n=61)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Bias-supporting tag clouds (n=56)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Balanced tag clouds (n=57)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Challenging explicit expert information (n=93)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Supporting expert information (n=81)
Number of subjects: 174
Study: 22997073

Group type: EXPERIMENTAL
Intervention: OBR + ENF
Number of subjects: 29

Group type: COMPARATOR
Intervention: OBR
Number of subjects: 29
Study: 20576837

Group type: EXPERIMENTAL
Intervention: Motion control, stability, or cushioned shoes based on plantar shape (experimental group)
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Stability shoe regardless of plantar shape (control group)
Number of subjects: 1111
Study: 18034628

Group type: EXPERIMENTAL
Intervention: Cultured autologous keratinocytes delivered on chemically defined transfer discs (Myskin)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cell-free discs (placebo)
Number of subjects: 16
Study: 16195293

Group type: EXPERIMENTAL
Intervention: Educational outreach sessions delivered to nurse practitioners (2-6 sessions).
Number of subjects: 1999
Study: 12097668

Group type: EXPERIMENTAL
Intervention: Leucine infusion at 4.1 mg/(kg. 12 h)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Leucine infusion at 6.6 mg/(kg. 12 h)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Leucine infusion at 8.3 mg/(kg. 12 h)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Leucine infusion (all rates)
Number of subjects: 10
Study: 9827735

Group type: EXPERIMENTAL
Intervention: 20-minute EMLA cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20-minute placebo cream
Number of subjects: 40
Study: 8116352

Group type: EXPERIMENTAL
Intervention: Marvelon (30 micrograms ethinyl estradiol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mercilon (20 micrograms ethinyl estradiol)
Number of subjects: 60
Study: 2571326

Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride ophthalmic solution
Number of subjects: 353

Group type: COMPARATOR
Intervention: Timolol maleate ophthalmic solution
Number of subjects: 353
Study: 22295

Group type: EXPERIMENTAL
Intervention: Droperidol premedication (0.3 to 0.5 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pentobarbital and Dolosal-promethazine
Number of subjects: 0
Study: 30357066

Group type: EXPERIMENTAL
Intervention: hEAR mobile application with Pioneer HDJ‐2000 headphones
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: hEAR mobile application with Sennheiser HD280 Pro headphones
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pure tone audiometric tests administered by an audiologist
Number of subjects: 30
Study: 26926659

Group type: EXPERIMENTAL
Intervention: Physical activity promotion
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Problem solving therapy (PST)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 176

Group type: COMPARATOR
Intervention: Lifestyle psychoeducation
Number of subjects: 176
Study: 25262862

Group type: EXPERIMENTAL
Intervention: Mapping and ablation of autonomic ganglia (AGP+)
Number of subjects: 47

Group type: COMPARATOR
Intervention: No mapping and ablation (AGP-)
Number of subjects: 47
Study: 22665430

Group type: EXPERIMENTAL
Intervention: Individual quizzes (intervention group I, n = 57)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Group quizzes (intervention group II, n = 56)
Number of subjects: 155

Group type: COMPARATOR
Intervention: No quizzes (control; intervention group III, n = 42)
Number of subjects: 155
Study: 18663642

Group type: EXPERIMENTAL
Intervention: Conventional visual scanning training combined with electrostimulation of the left hand
Number of subjects: 40

Group type: COMPARATOR
Intervention: Scanning training with sham stimulation
Number of subjects: 40
Study: 17767479

Group type: EXPERIMENTAL
Intervention: Relaxation training (four 90-min sessions in small groups)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard medical care (CON)
Number of subjects: 98
Study: 14962159

Group type: EXPERIMENTAL
Intervention: Idiopathic anemia (IA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Iron-deficiency anemia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anemia associated with chronic disease
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anemia of renal insufficiency
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Other causes of anemia
Number of subjects: 60
Study: 11472284

Group type: EXPERIMENTAL
Intervention: Propofol injection without iv carrier fluid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol injection with iv carrier fluid
Number of subjects: 30
Study: 9531581

Group type: EXPERIMENTAL
Intervention: Escherichia coli‐derived GM‐CSF (5 micrograms/kg/d by 6‐hour intravenous infusion) during induction chemotherapy.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo during induction chemotherapy.
Number of subjects: 240
Study: 8070287

Group type: EXPERIMENTAL
Intervention: Fungoid Tincture
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle Control
Number of subjects: 20
Study: 3281127

Group type: EXPERIMENTAL
Intervention: Sn-protoporphyrin
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control
Number of subjects: 122
Study: 1363660

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg o.d.)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Celiprolol (400 mg o.d.)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg o.d.)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg o.d.)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 319711

Group type: COMPARATOR
Intervention: Isoproterenol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Metaproterenol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 21
Study: 31056824

Group type: EXPERIMENTAL
Intervention: Early hard palate closure (EHPC) at 12 months
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Delayed hard palate closure (DHPC) at 36 months
Number of subjects: 122

Group type: COMPARATOR
Intervention: UCLP subjects compared to controls
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: UCLP subjects
Number of subjects: 122
Study: 28823927

Group type: EXPERIMENTAL
Intervention: Enhanced usual care alone
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Daily medication reminders via SMS text messages
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Medication monitoring via a patient portal-based assessment
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Both SMS text message reminders and portal-based medication monitoring
Number of subjects: 1505

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: All intervention strategies
Number of subjects: 1505
Study: 25624429

Group type: EXPERIMENTAL
Intervention: Orteronel 400 mg plus prednisone 5 mg twice daily
Number of subjects: 1099

Group type: COMPARATOR
Intervention: Placebo plus prednisone 5 mg twice daily
Number of subjects: 1099
Study: 24300224

Group type: EXPERIMENTAL
Intervention: Active anodal tDCS over the primary motor cortex (M1) at 2 mA for 20 minutes on 5 consecutive days.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (tDCS and sham)
Number of subjects: 20
Study: 22033040

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 320/9 μg
Number of subjects: 1219

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol pMDI 160/9 μg
Number of subjects: 1219

Group type: COMPARATOR
Intervention: formoterol dry powder inhaler 9 μg
Number of subjects: 1219
Study: 19309745

Group type: EXPERIMENTAL
Intervention: New chemotherapeutic agents
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies
Number of subjects: 1000
Study: 17524018

Group type: EXPERIMENTAL
Intervention: Supportive intervention involving an 18-hour course for health visitors, including 1-3 home visits during the first 5 weeks post-partum.
Number of subjects: 1597

Group type: COMPARATOR
Intervention: Usual practice by health visitors in the comparison group.
Number of subjects: 1597
Study: 15212192

Group type: EXPERIMENTAL
Intervention: Fast-release orodispersible tramadol tablet (Zamadol Melt)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional tramadol capsule
Number of subjects: 20
Study: 11434728

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 528

Group type: COMPARATOR
Intervention: Not taking HAART
Number of subjects: 528
Study: 9700035

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy with olive-allergen extracts (Stallergènes SA), 20 drops of 300 IR daily for 2 years
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy with olive-allergen extracts (Stallergènes SA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 7787006

Group type: EXPERIMENTAL
Intervention: Random-effects ordinal regression model
Number of subjects: 0
Study: 2691496

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic therapy for high-risk breast cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant combination chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primary (neoadjuvant) chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic adjuvant therapy
Number of subjects: 0
Study: 30137340

Group type: EXPERIMENTAL
Intervention: 300mg of micafungin twice weekly
Number of subjects: 20

Group type: COMPARATOR
Intervention: 100mg of micafungin once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 700mg once weekly (hypothetical regimen)
Number of subjects: 20
Study: 26873948

Group type: EXPERIMENTAL
Intervention: SASA! intervention
Number of subjects: 2532
Study: 24533393

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ondansetron 8 mg
Number of subjects: 100
Study: 22968501

Group type: EXPERIMENTAL
Intervention: Thoracoscopic surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: Thoracotomic surgery (Control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Conversion needed
Number of subjects: 44
Study: 20094786

Group type: EXPERIMENTAL
Intervention: Warm water instillation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Oil lubrication
Number of subjects: 117

Group type: COMPARATOR
Intervention: Conventional method with administration of antispasmodics
Number of subjects: 117
Study: 18571850

Group type: EXPERIMENTAL
Intervention: Heat pain threshold measurement at three equidistant sites of both volar forearms
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Heat pain tolerance measurement at three equidistant sites of both volar forearms
Number of subjects: 18
Study: 16020915

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (normocholesterolemic type 2 DM patients)
Number of subjects: 30
Study: 12525338

Group type: EXPERIMENTAL
Intervention: FACES III questionnaire in Spanish (México)
Number of subjects: 270
Study: 10376613

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg daily for 5 years)
Number of subjects: 1804

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1804
Study: 8785635

Group type: EXPERIMENTAL
Intervention: Two view technique
Number of subjects: 33734
Study: 1502960

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) with Haloperidol (30 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Haloperidol (30 mg/day)
Number of subjects: 20
Study: 6144974

Group type: EXPERIMENTAL
Intervention: Chemo-endocrine therapy (CMFp + T)
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Endocrine therapy (p + T)
Number of subjects: 783

Group type: COMPARATOR
Intervention: Control (no adjuvant treatment)
Number of subjects: 783
Study: 29667448

Group type: EXPERIMENTAL
Intervention: Short wavelength colours (blue/purple) with positively framed sunscreen pamphlet
Number of subjects: 286

Group type: COMPARATOR
Intervention: Long wavelength colours (red/orange) with negatively framed messages
Number of subjects: 286
Study: 26661570

Group type: EXPERIMENTAL
Intervention: Intravenous neostigmine (0.5 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Baseline motility
Number of subjects: 31
Study: 25262519

Group type: EXPERIMENTAL
Intervention: Flying Needle and Chinese herbal medicine
Number of subjects: 30
Study: 22209501

Group type: EXPERIMENTAL
Intervention: Low-calorie diet with bread (BREAD group)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Low-calorie diet without bread (NO BREAD group)
Number of subjects: 122
Study: 20233180

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 200 mg as 30-min intravenous infusion without probenecid
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ciprofloxacin 200 mg as 30-min intravenous infusion with 3 g probenecid divided into five oral doses
Number of subjects: 12
Study: 19094670

Group type: EXPERIMENTAL
Intervention: 7 day steroid withdrawal group
Number of subjects: 76

Group type: COMPARATOR
Intervention: 3 month steroid withdrawal group
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 76
Study: 16197815

Group type: EXPERIMENTAL
Intervention: High dose IGF-1 (3 microg/kg of body weight)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low dose IGF-1 (0.5 microg/kg of body weight)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 9
Study: 12390211

Group type: COMPARATOR
Intervention: Triple therapy (lansoprazole, amoxicillin, metronidazole)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Triple therapy plus vitamin C (250 mg) and vitamin E (200 mg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Triple therapy (lansoprazole, amoxicillin, metronidazole) for metronidazole susceptible isolates
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Triple therapy plus vitamin C and E for metronidazole susceptible isolates
Number of subjects: 104
Study: 10558313

Group type: EXPERIMENTAL
Intervention: Nasal intubation with the Trachlight
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral intubation with the Trachlight
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nasal and oral intubation
Number of subjects: 24
Study: 7747709

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) + Protein-bound polysaccharide (PSK)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) + Chemotherapy (CT)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) + Chemotherapy (CT) + Protein-bound polysaccharide (PSK)
Number of subjects: 174
Study: 2117622

Group type: EXPERIMENTAL
Intervention: High dose pro‐urokinase (9 million U)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Combination therapy (4.5 million U pro‐urokinase and 0.2 million U urokinase)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: High dose pro‐urokinase
Number of subjects: 75
Study: 6117684

Group type: EXPERIMENTAL
Intervention: Moderate salt restriction (from 200 to 50 mmol/day over 2 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High potassium intake
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined low sodium/high potassium intake
Number of subjects: 20
Study: 30654145

Group type: EXPERIMENTAL
Intervention: Laparoscopic-guided rectus sheath block (LGRSB) with ropivacaine hydrochloride
Number of subjects: 210

Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 210
Study: 28501884

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (32‐8 mg once daily for 20 days)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Omalizumab (injected every 2 or 4 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Mepolizumab (injected at baseline and at 4 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg on the first day, followed by 100 mg once daily for 20 days)
Number of subjects: 63
Study: 25708347

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 30 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 23645692

Group type: EXPERIMENTAL
Intervention: D-dimer levels ≥ 221 ng/mL (upper quartile)
Number of subjects: 17359

Group type: EXPERIMENTAL
Intervention: D-dimer levels between 221 ng/mL and upper tertile
Number of subjects: 17359

Group type: EXPERIMENTAL
Intervention: D-dimer levels between lower tertile and 221 ng/mL
Number of subjects: 17359

Group type: COMPARATOR
Intervention: D-dimer levels < 221 ng/mL (reference group)
Number of subjects: 17359
Study: 21248401

Group type: EXPERIMENTAL
Intervention: PTM+BT (PTM plus balneotherapy)
Number of subjects: 56

Group type: COMPARATOR
Intervention: PTM (PTM alone)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: PTM+HT (PTM plus hydrotherapy)
Number of subjects: 56
Study: 19409309

Group type: EXPERIMENTAL
Intervention: Forced-air warming blanket (group II, n = 22)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cotton blanket (group I, n = 22)
Number of subjects: 44